{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T03:46:05Z","timestamp":1776743165614,"version":"3.51.2"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2023RC290"],"award-info":[{"award-number":["2023RC290"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2025KY1658"],"award-info":[{"award-number":["2025KY1658"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013115","name":"Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013115","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.clml.2025.09.005","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:32:29Z","timestamp":1757550749000},"page":"e442-e451.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Causes of Death Among Waldenstr\u00f6m Macroglobulinemia Patients: A Population-Based Study"],"prefix":"10.1016","volume":"26","author":[{"given":"Dan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiongping","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiying","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clml.2025.09.005_bib0001","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41408-024-01194-5","article-title":"A comparative analysis of transformed indolent lymphomas and de novo diffuse large B-cell lymphoma: a population-based cohort study","volume":"14","author":"Vaughn","year":"2024","journal-title":"Blood Cancer J"},{"issue":"4","key":"10.1016\/j.clml.2025.09.005_bib0002","doi-asserted-by":"crossref","first-page":"100441","DOI":"10.1016\/j.modpat.2024.100441","article-title":"Fifth edition of the World Health Classification of Tumors of the hematopoietic and lymphoid tissues: b-cell neoplasms","volume":"37","author":"Medeiros","year":"2024","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clml.2025.09.005_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101129","article-title":"Current approach to Waldenstrom macroglobulinemia","volume":"62","author":"Kapoor","year":"2023","journal-title":"Blood Rev"},{"issue":"1","key":"10.1016\/j.clml.2025.09.005_bib0004","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3816\/CLML.2011.n.016","article-title":"Associated malignancies in patients with Waldenstrom\u2019s macroglobulinemia and their kin","volume":"11","author":"Hanzis","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"2","key":"10.1016\/j.clml.2025.09.005_bib0005","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/annonc\/mdr537","article-title":"Second malignancies among Waldenstrom macroglobulinemia patients: small samples and sparse data","volume":"23","author":"Ojha","year":"2012","journal-title":"Ann Oncol"},{"issue":"13","key":"10.1016\/j.clml.2025.09.005_bib0006","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/cncr.29334","article-title":"Incidence of secondary malignancies among patients with Waldenstrom macroglobulinemia: an analysis of the SEER database","volume":"121","author":"Castillo","year":"2015","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.clml.2025.09.005_bib0007","first-page":"1117","article-title":"The surveillance, epidemiology, and end results program: a national resource","volume":"8","author":"Hankey","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1016\/j.clml.2025.09.005_bib0008","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3109\/10428194.2011.557167","article-title":"Diffuse large B-cell lymphoma in the elderly: diffusion of treatment with rituximab and survival advances with and without anthracyclines","volume":"52","author":"Link","year":"2011","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"10.1016\/j.clml.2025.09.005_bib0009","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/1055-9965.EPI-12-0466","article-title":"Disparities in the early adoption of chemoimmunotherapy for diffuse large B-cell lymphoma in the United States","volume":"21","author":"Flowers","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"14","key":"10.1016\/j.clml.2025.09.005_bib0010","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.294.14.1765","article-title":"Comorbidity and survival disparities among black and white patients with breast cancer","volume":"294","author":"Tammemagi","year":"2005","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.clml.2025.09.005_bib0011","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1111\/bjh.19409","article-title":"Long-term results of Waldenstrom macroglobulinaemia treatment by bendamustine and rituximab: a study on behalf of the French Innovative Leukemia Organization (FILO)","volume":"204","author":"Laribi","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2025.09.005_bib0012","doi-asserted-by":"crossref","first-page":"1280033","DOI":"10.3389\/fonc.2023.1280033","article-title":"Hematologic secondary malignancies among 102 Chinese patients with waldenstrom\u2019s macroglobulinemia: a single-center case experience and literature review","volume":"13","author":"Wang","year":"2023","journal-title":"Front Oncol"},{"issue":"8","key":"10.1016\/j.clml.2025.09.005_bib0013","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/ajh.24052","article-title":"Survival outcomes of secondary cancers in patients with waldenstrom macroglobulinemia: an analysis of the SEER database","volume":"90","author":"Castillo","year":"2015","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.clml.2025.09.005_bib0014","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/annonc\/mdj111","article-title":"Characterization of familial Waldenstrom\u2019s macroglobulinemia","volume":"17","author":"Treon","year":"2006","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.clml.2025.09.005_bib0015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/bjh.17699","article-title":"Watch and wait in Waldenstrom macroglobulinaemia: looking for who to watch carefully and who can wait without worrying. Is it that simple?","volume":"195","author":"Durot","year":"2021","journal-title":"Br J Haematol"},{"issue":"16","key":"10.1016\/j.clml.2025.09.005_bib0016","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1200\/JCO.19.00394","article-title":"Progression risk stratification of asymptomatic waldenstrom macroglobulinemia","volume":"37","author":"Bustoros","year":"2019","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clml.2025.09.005_bib0017","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ajh.2830300202","article-title":"Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom\u2019s macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance","volume":"30","author":"Pilarski","year":"1989","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.clml.2025.09.005_bib0018","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/cid\/ciy458","article-title":"Increased risk of infectious complications in older patients with indolent Non-Hodgkin lymphoma exposed to bendamustine","volume":"68","author":"Fung","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.clml.2025.09.005_bib0019","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1182\/blood.V85.4.1144.bloodjournal8541144","article-title":"Monoclonal gammopathies and hepatitis C virus infection","volume":"85","author":"Mussini","year":"1995","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clml.2025.09.005_bib0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ajh.20724","article-title":"Hepatitis C viral infection is not associated with waldenstr\u00f6m\u2019s macroglobulinemia","volume":"82","author":"Leleu","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2025.09.005_bib0021","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jad.2025.02.027","article-title":"Breast cancer and suicide: a comprehensive systematic review and meta-analysis of suicidal behaviours mortality and risk factors among women with breast cancer","volume":"376","author":"Mudiyanselage","year":"2025","journal-title":"J Affect Disord"},{"issue":"2","key":"10.1016\/j.clml.2025.09.005_bib0022","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.35711","article-title":"A national estimate of mental disorders and mortality outcomes in cancer survivors","volume":"131","author":"Mai Tran","year":"2025","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.clml.2025.09.005_bib0023","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1007\/s11764-024-01732-x","article-title":"Risk assessment and predictive modeling of suicide in multiple myeloma patients","volume":"19","author":"Shen","year":"2024","journal-title":"J Cancer Surviv"},{"issue":"7","key":"10.1016\/j.clml.2025.09.005_bib0024","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2024.7024","article-title":"Diagnosis and risk stratification in Waldenstrom Macroglobulinemia","volume":"22","author":"Zanwar","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.clml.2025.09.005_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102715","article-title":"How to manage waldenstrom's macroglobulinemia in 2024","volume":"125","author":"Grunenberg","year":"2024","journal-title":"Cancer Treat Rev"},{"issue":"23","key":"10.1016\/j.clml.2025.09.005_bib0026","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1200\/JCO.2008.20.4677","article-title":"Primary therapy of Waldenstrom macroglobulinemia with bortezomib, dexamethasone, and rituximab: WMCTG clinical trial 05-180","volume":"27","author":"Treon","year":"2009","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.clml.2025.09.005_bib0027","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1182\/blood.2019000725","article-title":"How I treat Waldenstrom macroglobulinemia","volume":"134","author":"Dimopoulos","year":"2019","journal-title":"Blood,"},{"issue":"25","key":"10.1016\/j.clml.2025.09.005_bib0028","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1182\/blood-2014-05-574871","article-title":"Survival trends in Waldenstrom macroglobulinemia: an analysis of the surveillance, epidemiology and end results database","volume":"123","author":"Castillo","year":"2014","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.clml.2025.09.005_bib0029","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17050907","article-title":"Molecular mechanisms in the transformation from indolent to aggressive B. Cell Malignancies","volume":"17","author":"Maher","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.clml.2025.09.005_bib0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1053\/j.seminhematol.2023.03.005","article-title":"Report of consensus panel 1 from the 11(th) International Workshop on Waldenstrom\u2019s Macroglobulinemia on management of symptomatic, treatment-naive patients","volume":"60","author":"Buske","year":"2023","journal-title":"Semin Hematol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265025028952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265025028952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T03:18:45Z","timestamp":1776741525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265025028952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2152265025028952"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2025.09.005","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Causes of Death Among Waldenstr\u00f6m Macroglobulinemia Patients: A Population-Based Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2025.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}